Timothy Greco
Bala Cynwyd, PANPI 1952442378
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $137,329 of the $178,591 with a category attached, or 76.9%. AbbVie accounts for 74.3% of it on its own, with 2 other manufacturers making up the rest. Reporting peaked in 2019 at $55,648 and has fallen 84.8% since, to $8,471 in 2025.
Across 189 payments — averaging $944.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$133K
- Galderma Laboratories, L.p.$45K
- Merz North America, Inc.$521
What the payments were for
- Consulting fees$16,4009%
- Speaking & faculty fees$137,32977%
- Travel & lodging$21,46812%
- Food & beverage$3,3942%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 143 | $132,724 |
| Galderma Laboratories, L.p. | 37 | $45,345 |
| Merz North America, Inc. | 9 | $521 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$47,797
- BOTOX COSMETIC$35,759
- KYBELLA$1,950
- XEOMIN$125
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 12 | $520 |
| ValacyclovirValacyclovir Hcl | 26 | $487 |
| Mupirocin | 46 | $299 |
| Ketorolac Tromethamine | 13 | $167 |
| Cephalexin | 14 | $90 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $42 |
| Ondansetron OdtOndansetron | 22 | $33 |
| Zolpidem Tartrate | 12 | $23 |
| Diazepam | 14 | $17 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.